GCM
PYXS icon

Graham Capital Management’s Pyxis Oncology PYXS Stock Holding History

Graham Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2K Sell
22,748
-161,194
-88% -$243K ﹤0.01% 1105
2025
Q4 		$212K Buy
+183,942
New +$649K 0.01% 1023
2025
Q1 		– Sell
-30,287
Closed -$47.2K – 1477
2024
Q4 		$47.2K Buy
+30,287
New +$87.4K ﹤0.01% 1182

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's PYXS Position: Q1 2026 in Review

Graham Capital Management reduced its Pyxis Oncology (PYXS) stake by 88% in Q1 2026, selling an estimated $243K and leaving 22,748 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

Graham Capital Management first reported a position in PYXS in Q4 2024 and has held it in 3 quarters since. The position peaked at $212K in Q4 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Graham Capital Management held 22,748 shares of Pyxis Oncology worth $33.2K as of Q1 2026.
  • Graham Capital Management sold 161,194 Pyxis Oncology shares in Q1 2026, an estimated $243K.
  • Pyxis Oncology made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #1105 holding.
  • Graham Capital Management first reported a position in Pyxis Oncology in Q4 2024 and has held it in 3 quarters since.
  • Graham Capital Management's Pyxis Oncology position peaked at $212K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.